Harrow, Inc. offers speculative gains from $20s to $30s, with Q4 growth, bullish 2025 revenue guidance, and long-term growth ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

FOLLOWING news of three deaths being linked to an NHS listeria outbreak, let me explain what the bug is and if you’re at risk ...

NHS patients at specialist eye hospital group Optegra have reaped the benefits of a unique approach to cataract surgery ...

Steroids, commonly used to treat inflammation, asthma, allergies, arthritis, and autoimmune diseases, can pose a serious risk ...

Regular eye check-ups are essential, especially for high-risk groups. Misuse of steroids can exacerbate the risk. Early diagnosis is crucial to prevent visual disability. World Glaucoma Week ...

ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) ...

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for ... patients with diabetic eye disease,” Khanani, who led ...

Myopic macular degeneration (MMD) is a serious eye condition that can cause vision loss that gets worse over time. Treatment may help reduce complications of MMD. Myopic macular degeneration (MMD ...